Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naïve HIV-2-infected patients: The ACHIEV2E collaboration study group

  1. Benard, A.
  2. Van Sighem, A.
  3. Taieb, A.
  4. Valadas, E.
  5. Ruelle, J.
  6. Soriano, V.
  7. Calmy, A.
  8. Balotta, C.
  9. Damond, F.
  10. Brun-Vezinet, F.
  11. Chene, G.
  12. Matheron, S.
Aldizkaria:
Clinical Infectious Diseases

ISSN: 1058-4838,  1537-6591

Argitalpen urtea: 2011

Alea: 52

Zenbakia: 10

Orrialdeak: 1257-1266

Mota: Artikulua

DOI: 10.1093/CID/CIR123 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus